| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CURIS INC | Head of Research & Development | Employee stock option (right to buy) | 350,000 | $4,067,000 | $11.62 | 20 Jan 2023 | Direct |
| Indaptus Therapeutics, Inc. | Director | Stock Option (right to buy) | 12,500 | $888 | $0.0710 | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | 10 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 16:05 |
| INDP | Indaptus Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 17:00 |
| INDP | Indaptus Therapeutics, Inc. | 13 Feb 2023 | 1 | $0 | 4 | Director | 14 Feb 2023, 16:58 |
| INDP | Indaptus Therapeutics, Inc. | 13 Feb 2023 | 0 | $0 | 3 | Director | 14 Feb 2023, 16:55 |
| CRIS | CURIS INC | 20 Jan 2023 | 1 | $0 | 4 | Head of Research & Development | 24 Jan 2023, 15:09 |
| CRIS | CURIS INC | 29 Jan 2022 | 1 | $0 | 4 | Head of Research & Development | 31 Jan 2022, 16:16 |